Daniel Shouval, M.D.

Dr. Daniel Shouval is a graduate of the Hadassah-Hebrew University Medical School in Jerusalem, Israel. After training in Internal Medicine, Dr. Shouval was trained in Cell Biology, Immunology, and Molecular Biology at the Liver Research Center at Albert Einstein College of Medicine in New York, and the Massachusetts General Hospital in Boston. His main research interests and publications include pathobiology of, and immune response to hepatitis B virus infection and hepatocellular carcinoma, as well as assessment of new vaccines against hepatitis B and A infections. In recent years his main efforts are focused on the development and clinical trials with a third generation Pre-S/S hepatitis B vaccine, intervention in persistent HBV infection, prevention of HBV infection in liver transplant recipients and adoptive transfer of immunity. Dr. Shouval is the recipient of several national and international awards and the author of over 180 publications and chapters in books. He is currently Professor of Medicine and the Director of the Liver Unit of Hadassah University Hospital in Jerusalem. He is a visiting Professor at the Albert Einstein College of Medicine in New York and had similar positions at the Harvard Medical School and Massachusetts General Hospital in Boston, USA and in the University of Paris, France. In 1996 Prof. Shouval was President of the European Association for the Study of the Liver. Since 1998 he is Chairman of the Educational Committee of the European Association for the Study of the Liver. Currently Dr. Shouval is Associate Editor of the journal Liver Transplantation and member of the Editorial Boards in several hepatology journals.